- Home
- IMPP vs COYA Comparison
IMPP vs COYA Comparison
Compare IMPP & COYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMPP
- COYA
- Stock Information
- Founded
- IMPP 1981
- COYA 2020
- Country
- IMPP Greece
- COYA United States
- Employees
- IMPP N/A
- COYA N/A
- Industry
- IMPP Marine Transportation
- COYA Biotechnology: Pharmaceutical Preparations
- Sector
- IMPP Consumer Discretionary
- COYA Health Care
- Exchange
- IMPP Nasdaq
- COYA Nasdaq
- Market Cap
- IMPP 100.2M
- COYA 93.9M
- IPO Year
- IMPP N/A
- COYA 2022
- Fundamental
- Price
- IMPP $2.97
- COYA $5.38
- Analyst Decision
- IMPP
- COYA Strong Buy
- Analyst Count
- IMPP 0
- COYA 4
- Target Price
- IMPP N/A
- COYA $16.25
- AVG Volume (30 Days)
- IMPP 279.7K
- COYA 62.0K
- Earning Date
- IMPP 02-11-2025
- COYA 11-06-2024
- Dividend Yield
- IMPP N/A
- COYA N/A
- EPS Growth
- IMPP N/A
- COYA N/A
- EPS
- IMPP 1.51
- COYA N/A
- Revenue
- IMPP $151,150,129.00
- COYA $9,554,315.00
- Revenue This Year
- IMPP N/A
- COYA N/A
- Revenue Next Year
- IMPP $36.01
- COYA $87.80
- P/E Ratio
- IMPP $1.97
- COYA N/A
- Revenue Growth
- IMPP N/A
- COYA N/A
- 52 Week Low
- IMPP $2.72
- COYA $4.75
- 52 Week High
- IMPP $4.59
- COYA $10.69
- Technical
- Relative Strength Index (RSI)
- IMPP 42.88
- COYA 38.98
- Support Level
- IMPP $3.08
- COYA $5.52
- Resistance Level
- IMPP $3.40
- COYA $6.14
- Average True Range (ATR)
- IMPP 0.21
- COYA 0.44
- MACD
- IMPP 0.01
- COYA -0.01
- Stochastic Oscillator
- IMPP 21.26
- COYA 5.13
About IMPP Imperial Petroleum Inc.
Imperial Petroleum Inc is a provider of international seaborne transportation services to oil producers, refineries, and commodities traders. It owns and operates a fleet of six medium-range product tankers that carry refined petroleum products such as gasoline, diesel, fuel oil and jet fuel, as well as edible oils and chemicals.
About COYA Coya Therapeutics Inc.
Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary medicinal products to modulate the function of regulatory T cells. It is developing its multi-modality Treg therapies for neurodegenerative, autoimmune, and metabolic diseases.